ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

FXI Fusionex

63.50
0.00 (0.00%)
19 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Fusionex LSE:FXI London Ordinary Share JE00B8BL8C53 ORD NPV
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 63.50 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Fusionex International PLC Contract win with healthcare system provider (8595B)

07/04/2017 7:00am

UK Regulatory


Fusionex (LSE:FXI)
Historical Stock Chart


From Jun 2019 to Jun 2024

Click Here for more Fusionex Charts.

TIDMFXI

RNS Number : 8595B

Fusionex International PLC

07 April 2017

 
 RNS   7 April 2017 
 

Fusionex International PLC

("Fusionex" or the "Group")

Contract win with multinational healthcare system provider

Fusionex, a leading provider of Analytics and Big Data software, is pleased to announce that it has won a new contract with a major multinational Asian healthcare company for GIANT 2017, its award-winning Big Data platform. The initial contract with the medical supplier is in the region of USD300,000, with the value expected to increase alongside the adoption rate within the client's various departments and at different offices across Asia.

GIANT 2017 will enable the client to gain intelligent e-commerce insights to boost revenues and improve overall system management by the medical professionals across the business through a wide spectrum of data analytics. GIANT 2017 enables administrators to monitor user preferences and needs, as well as identify the preferences of medical professionals whether in terms of equipment, events or reading materials.

The integrated regional medical supplier of equipment, supplies, and services supports a network of thousands of healthcare institutions, including government and private hospitals, surgery centers, specialist and primary care clinics, laboratories, and nursing homes across Asia.

Ivan Teh, Chief Executive Officer of Fusionex, commented:

"This GIANT win further demonstrates the capability and applicability of Big Data Analytics to the healthcare industry, a core focus for Fusionex. We are delighted to enter into the relationship and we know that the insights and benefits that GIANT will bring to medical professionals will ultimately help thousands of patients. The adoption of Big Data in healthcare is crucial and we believe that Fusionex will continue to generate significant revenues from the sector."

For further details:

Fusionex

 
 Ivan Teh, Chief Executive Officer          Through Buchanan 
  Yuen Choong Lai, Chief Financial 
  Officer 
  Darren Hopkins, Director of Investor 
  Relations & Corporate Development 
 Stifel 
  Fred Walsh, Neil Shah, Ben Maddison, 
  Rajpal Padam                                 0207 710 7600 
 Peel Hunt                                     0207 418 8900 
 Richard Kauffer, Euan Brown 
 Buchanan 
  Giles Sanderson, Steph Watson, Patrick 
  Hanrahan                                     020 7466 5000 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

CNTUNUNRBAASRAR

(END) Dow Jones Newswires

April 07, 2017 02:00 ET (06:00 GMT)

1 Year Fusionex Chart

1 Year Fusionex Chart

1 Month Fusionex Chart

1 Month Fusionex Chart